Literature DB >> 21247927

Novel procedure- and device-based strategies in the management of systemic hypertension.

Henry Krum1, Markus Schlaich, Paul Sobotka, Ingrid Scheffers, Abraham A Kroon, Peter W de Leeuw.   

Abstract

Despite the considerable advances in the treatment of hypertension that have been made over the past few decades, adequate management and control of this condition remains poor, and efforts are ongoing to develop new strategies to improve related outcomes. Novel therapeutic approaches to the management of systemic hypertension fall into two major categories: (i) those that seek to improve blood pressure-lowering efficacy using new therapeutic strategies in addition to standard non-pharmacological and pharmacological approaches and (ii) novel ways to optimize and improve the efficacy and utility of existing therapies. Novel procedure- and device-based strategies to control hypertension include renal sympathetic denervation and baroreflex sensitization. These two techniques will be the focus of the present review.

Entities:  

Mesh:

Year:  2011        PMID: 21247927     DOI: 10.1093/eurheartj/ehq457

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

Review 1.  Key advances in antihypertensive treatment.

Authors:  Ludovit Paulis; Ulrike M Steckelings; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2012-03-20       Impact factor: 32.419

2.  Renal Sympathetic Denervation for Treatment of Hypertension.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02-01

Review 3.  A perspective on sympathetic renal denervation in chronic congestive heart failure.

Authors:  Raef Madanieh; Mohammed El-Hunjul; Hassan Alkhawam; Constantine E Kosmas; Abed Madanieh; Timothy J Vittorio
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

4.  Renal denervation therapy for resistant hypertension.

Authors:  Mark Davis; Ernesto L Schiffrin; Dominique Joyal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-12

Review 5.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

6.  Durable strong efficacy and favorable long-term renal safety of the anatomically optimized distal renal denervation according to the 3 year follow-up extension of the double-blind randomized controlled trial.

Authors:  Stanislav Pekarskiy; Andrei Baev; Alla Falkovskaya; Valeria Lichikaki; Ekaterina Sitkova; Irina Zubanova; Musheg Manukyan; Mikhail Tarasov; Viktor Mordovin; Sergei Popov
Journal:  Heliyon       Date:  2022-01-13

Review 7.  Renal denervation for treating resistant hypertension: current evidence and future insights from a global perspective.

Authors:  Y Castro Torres; Richard E Katholi
Journal:  Int J Hypertens       Date:  2013-11-27       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.